MedPath

Role of Barley in the treatment of Kidney Stones

Phase 4
Completed
Conditions
Patients suffering with all types of Renal Calculi
Registration Number
CTRI/2014/10/005154
Lead Sponsor
Dr K V Chakradhar
Brief Summary

The incidence of renal calculi (urolithiasis) isincreasing in both developed and developing countries. It is estimated that 12%of world population experiences renal stone disease with a recurrence rate of70-80% in males and 47-60% in females.  Urolithiasis carries high risk of recurrenceafter the initial episode, of around 50% at 5 years and 70% at 9 years. Searchfor alternative medicines available at low cost which exhibit least adverseeffects are anticipated to benefit many poor patients with renal calculi. Ithas been described in Ayurveda that Hordeum vulgare is effective in theexpulsion of renal calculi. SuÅ›ruta the father of surgery explained urinary calculusunder the heading of Ashmari in details including etiological factors,classification, symptomatology, pathology, complications and its management ina most scientific manner. This disease is dreadful and hence considered one ofthe ‘**MahÄgadÄs**’ by SuÅ›ruta, may beowing to its potentiality to disturb the anatomy and physiology of urinarysystem. The old bladder stone is reported at “ELAMARAH†in Upper Egypt, datedabout 4800 BC, shows that humans of ancient time were undoubtedly affected withthe disease Ashmari just as humans are now. Å–igveda and Atharavaveda (2000 –5000 BC) also mentioned the stone and advise people not to ride a horse, Carakahas advised medical management and SuÅ›ruta advised both conservative andsurgical removal of stone through perineal root cystolithotomy.All the Acharyas except Charaka have classified the disease MÅ«trÄÅ›mari intofour types.

i.e. i.) Shleshmaja Ashmari

ii.) Pittaja Ashmari

iii.) Vataja Ashmari

iv) *ShukrajaAshmari*

Management of various types of *Ashmari* has been described in *SuÅ›ruta SamhitÄ* in view of the fatalityof the diseases treatment has been advised to be undertaken in the early stagesof the disease. *GhÅ—ta* recipes forthree types of calculi have been mentioned along with indication of appropriatefood, drinks and other measures, where he exclusively described about the usageof *Yava Kshara*.Indication for the surgical management has been givenalong with a note of caution regarding its dangers and doubtful chances ofsuccess. It was to be undertaken only on failure of conservative treatment andwhen death was inevitable if not treated surgically**.** However,there is no comprehensive analysis and the formulation has not beenscientifically validated. Ours is the first attempt to validate the formulationdescribed in Ayurveda. Development of new formulations which are likely to becheaper and exhibit minimal or no adverse effects will be beneficial. Thepreliminary results advocate undertaking systematic scientific studies of the Hordeumvulgare formulation in the management of renal calculi. In view of the abovefacts and also the existing clinical trial data, it is proposed to validate theformulation through systematic studies.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

•Sex: Either sex •Radiological evidence of stone (>5 mm to <10 mm) in Kidney, Ureter and Urinary Bladder.

Exclusion Criteria
  • •Stone size more than 10 mm.
  • •Impacted stone.
  • •Gross Hydronephrosis.
  • •Pyelonephritis.
  • •Uncontrolled Diabetic Mellitus and Hypertension •Malignancy.
  • •Impaired Renal Function.
  • •Poorly Functioning Kidney.
  • •Patients with obstruction in urinary passage.
  • •Patients with known metabolic abnormality for calculus formation (Hyperuraecemia).
  • •Any other complication of calculus.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.expulsion of the renal calculi90 days
Secondary Outcome Measures
NameTimeMethod
1.ability in reducing the size of the calculi2.Improved quality of life

Trial Locations

Locations (1)

Department of Shalya

🇮🇳

Chittoor, ANDHRA PRADESH, India

Department of Shalya
🇮🇳Chittoor, ANDHRA PRADESH, India
Dr KV Chakradhar
Principal investigator
919494100913
chakri52341@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.